These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 2884113

  • 1. Human renovascular effects of dopexamine hydrochloride: a novel agonist of peripheral dopamine and beta 2-adreno-receptors.
    Magrini F, Foulds R, Roberts N, Macchi G, Mondadori C, Zanchetti A.
    Eur J Clin Pharmacol; 1987; 32(1):1-4. PubMed ID: 2884113
    [Abstract] [Full Text] [Related]

  • 2. Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure.
    Jamison M, Widerhorn J, Weber L, Campese V, Vasquez J, Hovanessian L, Rahimtoola SH, Elkayam U.
    Am Heart J; 1989 Mar; 117(3):607-14. PubMed ID: 2537556
    [Abstract] [Full Text] [Related]

  • 3. The effects of dopexamine on the cardiovascular system of the dog.
    Brown RA, Farmer JB, Hall JC, Humphries RG, O'Connor SE, Smith GW.
    Br J Pharmacol; 1985 Jul; 85(3):609-19. PubMed ID: 4027482
    [Abstract] [Full Text] [Related]

  • 4. [Dopexamine: a new dopaminergic agonist].
    Perrin G, Papazian L, Martin C.
    Ann Fr Anesth Reanim; 1993 Jul; 12(3):308-20. PubMed ID: 7902685
    [Abstract] [Full Text] [Related]

  • 5. Arrhythmogenic potential of dopexamine hydrochloride during halothane anaesthesia in dogs.
    Neustein SM, Dimich I, Sampson I, Sadeghi A, Mezrow C, Shiang H.
    Can J Anaesth; 1994 Jun; 41(6):542-6. PubMed ID: 7915210
    [Abstract] [Full Text] [Related]

  • 6. Haemodynamic and renal effects of dopexamine after cardiac surgery in children.
    Habre W, Beghetti M, Roduit C, Girardin E, Vallotton M, Friedli B, Berner M.
    Anaesth Intensive Care; 1996 Aug; 24(4):435-9. PubMed ID: 8862639
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular pharmacology of dopexamine in low output congestive heart failure.
    Leier CV, Binkley PF, Carpenter J, Randolph PH, Unverferth DV.
    Am J Cardiol; 1988 Jul 01; 62(1):94-9. PubMed ID: 2898209
    [Abstract] [Full Text] [Related]

  • 8. Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.
    Brown RA, Dixon J, Farmer JB, Hall JC, Humphries RG, Ince F, O'Connor SE, Simpson WT, Smith GW.
    Br J Pharmacol; 1985 Jul 01; 85(3):599-608. PubMed ID: 2862944
    [Abstract] [Full Text] [Related]

  • 9. Dopexamine hydrochloride, a beta 2 adrenergic and dopaminergic agonist; haemodynamic effects following cardiac surgery.
    Hakim M, Foulds R, Latimer RD, English TA.
    Eur Heart J; 1988 Aug 01; 9(8):853-8. PubMed ID: 2903053
    [Abstract] [Full Text] [Related]

  • 10. Prolonged infusion of varied doses of dopexamine hydrochloride for low cardiac output after cardiac surgery.
    Santman FW.
    J Cardiothorac Vasc Anesth; 1992 Oct 01; 6(5):568-72. PubMed ID: 1358247
    [Abstract] [Full Text] [Related]

  • 11. Comparative study of effects of adrenaline, dobutamine and dopamine on systemic hemodynamics and renal blood flow in patients following open heart surgery.
    Sato Y, Matsuzawa H, Eguchi S.
    Jpn Circ J; 1982 Oct 01; 46(10):1059-72. PubMed ID: 7120650
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular and renal haemodynamic effects of dopexamine: comparison with dopamine.
    Stephan H, Sonntag H, Henning H, Yoshimine K.
    Br J Anaesth; 1990 Sep 01; 65(3):380-7. PubMed ID: 1977432
    [Abstract] [Full Text] [Related]

  • 13. Effects of chronic intravenous infusions of dopexamine and isoprenaline to rats on D1-, beta 1- and beta 2-receptor-mediated responses.
    Martin SW, Broadley KJ.
    Br J Pharmacol; 1994 Jun 01; 112(2):595-603. PubMed ID: 7915614
    [Abstract] [Full Text] [Related]

  • 14. The cardiovascular actions of dopexamine hydrochloride, an agonist at dopamine receptors and beta 2-adrenoceptors in the dog.
    Smith GW, Hall JC, Farmer JB, Simpson WT.
    J Pharm Pharmacol; 1987 Aug 01; 39(8):636-41. PubMed ID: 2888855
    [Abstract] [Full Text] [Related]

  • 15. Enhancing liver blood flow after cardiopulmonary bypass: the effects of dopamine and dopexamine.
    Sharpe DA, Mitchel IM, Kay EA, McGoldrick JP, Munsch CM, Kay PH.
    Perfusion; 1999 Jan 01; 14(1):29-36. PubMed ID: 10074644
    [Abstract] [Full Text] [Related]

  • 16. Effect of dopexamine hydrochloride on renal vascular resistance index and haemodynamic responses following coronary artery bypass graft surgery.
    Sherry E, Tooley MA, Bolsin SN, Monk CR, Willcox J.
    Eur J Anaesthesiol; 1997 Mar 01; 14(2):184-9. PubMed ID: 9088818
    [Abstract] [Full Text] [Related]

  • 17. Inotropic mechanisms of dopexamine hydrochloride in horses.
    Muir WW.
    Am J Vet Res; 1992 Aug 01; 53(8):1343-6. PubMed ID: 1354950
    [Abstract] [Full Text] [Related]

  • 18. Renal effect of dopexamine hydrochloride in patients with chronic renal dysfunction.
    Atallah MM, Saied MM, el-Diasty TA, Gray PA, Park GR.
    Urol Res; 1992 Aug 01; 20(6):419-24. PubMed ID: 1462481
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Role of the beta 2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochloride.
    Lang RM, Borow KM, Neumann A, Carroll JD, Weinert L, Murphy MB, Ghali J, Rajfer SI.
    Am J Cardiol; 1988 Aug 11; 62(5):46C-52C. PubMed ID: 2841838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.